Detalhe da pesquisa
1.
Extending Treatment Intervals of R-CHOP Therapy Might Be Acceptable for Some Patients with Non-indolent Non-Hodgkin's B-cell Lymphoma.
Acta Med Okayama
; 76(1): 17-24, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35236994
2.
Idiopathic Pneumonia Syndrome Refractory to Ruxolitinib after Post-Transplant Cyclophosphamide-based Haploidentical Hematopoietic Stem Cell Transplantation: Lung Pathological Findings from an Autopsy Case.
Acta Med Okayama
; 76(5): 609-615, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36352810
3.
A Disseminated Fusarium fujikuroi Species Complex Infection Prior to Allogeneic Hematopoietic Stem Cell Transplantation.
Acta Med Okayama
; 74(5): 435-441, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106701
4.
[Pneumatosis cystoides intestinalis developing subsequent to allogeneic hematopoietic stem cell transplantation for mixed phenotype acute leukemia].
Rinsho Ketsueki
; 61(4): 312-317, 2020.
Artigo
em Japonês
| MEDLINE | ID: mdl-32378572
5.
Doripenem versus meropenem as first-line empiric therapy of febrile neutropenia in patients with acute leukemia: a prospective, randomized study.
Ann Hematol
; 98(5): 1209-1216, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30824955
6.
Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab.
Leukemia
; 35(3): 929-931, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33597730